125 related articles for article (PubMed ID: 30728912)
1. Correction: Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis.
Hsu YL; Hung JY; Lee YL; Chen FW; Chang KF; Chang WA; Tsai YM; Chong IW; Kuo PL
Oncotarget; 2019 Jan; 10(5):616. PubMed ID: 30728912
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis.
Hsu YL; Hung JY; Lee YL; Chen FW; Chang KF; Chang WA; Tsai YM; Chong IW; Kuo PL
Oncotarget; 2017 Dec; 8(62):104831-104854. PubMed ID: 29285217
[TBL] [Abstract][Full Text] [Related]
3. Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in
Patkar N; Kodgule R; Kakirde C; Raval G; Bhanshe P; Joshi S; Chaudhary S; Badrinath Y; Ghoghale S; Kadechkar S; Khizer SH; Kannan S; Shetty D; Gokarn A; Punatkar S; Jain H; Bagal B; Menon H; Sengar M; Khattry N; Tembhare P; Subramanian P; Gujral S
Oncotarget; 2019 Jan; 10(5):617. PubMed ID: 30728913
[TBL] [Abstract][Full Text] [Related]
4. Correction: Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.
Ciribilli Y; Borlak J
Oncotarget; 2018 Dec; 9(98):37269. PubMed ID: 30647859
[TBL] [Abstract][Full Text] [Related]
5. Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; Vecchia C; Sozzi G; Pastorino U
Oncotarget; 2019 Oct; 10(57):6043. PubMed ID: 31666934
[TBL] [Abstract][Full Text] [Related]
6. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
7. Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer.
Gordian E; Welsh EA; Gimbrone N; Siegel EM; Shibata D; Creelan BC; Cress WD; Eschrich SA; Haura EB; Muñoz-Antonia T
Oncotarget; 2021 Jun; 12(13):1325. PubMed ID: 34194632
[TBL] [Abstract][Full Text] [Related]
8. Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB.
Feng PH; Yu CT; Chen KY; Luo CS; Wu SM; Liu CY; Kuo LW; Chan YF; Chen TT; Chang CC; Lee CN; Chuang HC; Lin CF; Han CL; Lee WH; Lee KY
Oncotarget; 2018 Jul; 9(59):31559. PubMed ID: 30140390
[TBL] [Abstract][Full Text] [Related]
9. Correction: Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts.
Yang L; Forker L; Irlam JJ; Pillay N; Choudhury A; West CML
Oncotarget; 2019 Mar; 10(20):2007. PubMed ID: 30956781
[TBL] [Abstract][Full Text] [Related]
10. Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study.
Velizheva NP; Rechsteiner MP; Valtcheva N; Freiberger SN; Wong CE; Vrugt B; Zhong Q; Wagner U; Moch H; Hillinger S; Schmitt-Opitz I; Soltermann A; Wild PJ; Tischler V
Pathol Res Pract; 2018 Apr; 214(4):572-578. PubMed ID: 29580750
[TBL] [Abstract][Full Text] [Related]
11. Correction: Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.
Arundhathi A; Chuang WH; Chen JK; Wang SE; Shyr YM; Chen JY; Liao WN; Chen HW; Teng YM; Pai CC; Wang CH
Oncotarget; 2019 Jan; 10(4):558. PubMed ID: 30728905
[TBL] [Abstract][Full Text] [Related]
12. Correction: The different pathogenesis of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum.
Niwa A; Kuwano S; Tomita H; Kimura K; Orihara Y; Kanayama T; Noguchi K; Hisamatsu K; Nakashima T; Hatano Y; Hirata A; Miyazaki T; Kaneko K; Tanaka T; Hara A
Oncotarget; 2018 Feb; 9(13):11427. PubMed ID: 29541424
[TBL] [Abstract][Full Text] [Related]
13. Correction: Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
Zhou J; Li Y; Zhang Y; Liu G; Tan H; Hu Y; Xiao J; Shi H
Oncotarget; 2019 Feb; 10(11):1224. PubMed ID: 30838094
[TBL] [Abstract][Full Text] [Related]
14. Correction: Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer.
Terlizzi M; Colarusso C; De Rosa I; De Rosa N; Somma P; Curcio C; Sanduzzi A; Micheli P; Molino A; Saccomanno A; Salvi R; Aquino RP; Pinto A; Sorrentino R
Oncotarget; 2018 Jun; 9(50):29537. PubMed ID: 30034638
[TBL] [Abstract][Full Text] [Related]
15. Correction: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy.
Hsu TI; Chen YJ; Hung CY; Wang YC; Lin SJ; Su WC; Lai MD; Kim SY; Wang Q; Qian K; Goto M; Zhao Y; Kashiwada Y; Lee KH; Chang WC; Hung JJ
Oncotarget; 2019 Nov; 10(60):6536-6537. PubMed ID: 31741716
[TBL] [Abstract][Full Text] [Related]
16. Correction: Quinacrine inhibits GSTA1 activity and induces apoptosis through G
Kumar M; Martin A; Nirgude S; Chaudhary B; Mondal S; Sarkar A
Oncotarget; 2020 Nov; 11(46):4364-4365. PubMed ID: 33245730
[TBL] [Abstract][Full Text] [Related]
17. Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability.
Munari E; Zamboni G; Marconi M; Sommaggio M; Brunelli M; Martignoni G; Netto GJ; Moretta F; Mingari MC; Salgarello M; Terzi A; Picece V; Pomari C; Lunardi G; Cavazza A; Rossi G; Moretta L; Bogina G
Oncotarget; 2018 Dec; 9(97):37077. PubMed ID: 30651938
[TBL] [Abstract][Full Text] [Related]
18. Correction: Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach.
Xiao Z; Sperl B; Gärtner S; Nedelko T; Stacher-Priehse E; Ullrich A; Knyazev PG
Oncotarget; 2021 Aug; 12(17):1734-1735. PubMed ID: 34434503
[TBL] [Abstract][Full Text] [Related]
19. Correction: Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel.
McDonald JT; Kritharis A; Beheshti A; Pilichowska M; Burgess K; Ricks-Santi L; McNiel E; London CA; Ravi D; Evens AM
Oncotarget; 2018 Sep; 9(70):33441. PubMed ID: 30279973
[TBL] [Abstract][Full Text] [Related]
20. Correction: Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics,
Zhang Y; Li ZY; Hou XX; Wang X; Luo YH; Ying YP; Chen G
Oncotarget; 2022; 13():518-520. PubMed ID: 35284039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
